Cargando…

Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment

The gut microbiota plays an important role in regulating the pharmacokinetics and pharmacodynamics of many drugs. FLZ, a novel squamosamide derivative, has been shown to have neuroprotective effects on experimental Parkinson's disease (PD) models. FLZ is under phase Ⅰ clinical trial now, while...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shang, Junmei, Ma, Shurong, Zang, Caixia, Bao, Xiuqi, Wang, Yan, Zhang, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148066/ https://www.ncbi.nlm.nih.gov/pubmed/34094829 http://dx.doi.org/10.1016/j.apsb.2021.01.009

Ejemplares similares

Squamosamide Derivative FLZ Diminishes Aberrant Mitochondrial Fission by Inhibiting Dynamin-Related Protein 1
por: Yang, Hanyu, et al.
Publicado: (2021)

Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis
por: Zhao, Zhe, et al.
Publicado: (2021)

Src Inhibition Attenuates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson’s Disease Models
por: Yang, Hanyu, et al.
Publicado: (2020)

P-Glycoprotein Mediated Efflux Limits the Transport of the Novel Anti-Parkinson's Disease Candidate Drug FLZ across the Physiological and PD Pathological In Vitro BBB Models
por: Liu, Qian, et al.
Publicado: (2014)

Genome-wide Identification and Characterization of FCS-Like Zinc Finger (FLZ) Family Genes in Maize (Zea mays) and Functional Analysis of ZmFLZ25 in Plant Abscisic Acid Response
por: Chen, Shunquan, et al.
Publicado: (2021)

Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity
por: Zhang, Dan, et al.
Publicado: (2008)

FLZ Alleviates the Memory Deficits in Transgenic Mouse Model of Alzheimer’s Disease via Decreasing Beta-Amyloid Production and Tau Hyperphosphorylation
por: Bao, Xiu-Qi, et al.
Publicado: (2013)

An In Vivo Microdialysis Study of FLZ Penetration through the Blood-Brain Barrier in Normal and 6-Hydroxydopamine Induced Parkinson's Disease Model Rats
por: Hou, Jinfeng, et al.
Publicado: (2014)

Gardenia jasminoides J. Ellis extract GJ-4 attenuates hyperlipidemic vascular dementia in rats via regulating PPAR-γ-mediated microglial polarization
por: Liu, Hui, et al.
Publicado: (2022)

Squamosamide Derivative FLZ Protects Pancreatic β-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway
por: Kong, Xiangchen, et al.
Publicado: (2015)

Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
por: Zhao, Zhe, et al.
Publicado: (2021)

Integrin CD11b mediates α-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway
por: Hou, Liyan, et al.
Publicado: (2017)

New hope for Parkinson's disease treatment: Targeting gut microbiota
por: Fan, Hong‐Xia, et al.
Publicado: (2022)

Genome-wide identification and expression reveal the involvement of the FCS-like zinc finger (FLZ) gene family in Gossypium hirsutum at low temperature
por: Wang, JunDuo, et al.
Publicado: (2023)

Gut microbiota: Implications in Parkinson's disease
por: Parashar, Arun, et al.
Publicado: (2017)

Mendelian Randomisation Study on Association of Gut Microbiota and Periodontitis
por: Song, Jukun, et al.
Publicado: (2023)

Gut Microbiota Approach—A New Strategy to Treat Parkinson’s Disease
por: Liu, Jing, et al.
Publicado: (2020)

The multifaceted roles of common gut microbiota in immune checkpoint inhibitor-mediated colitis: From mechanism to clinical application
por: Han, Xu, et al.
Publicado: (2022)

Gut Microbiota-Mediated Drug-Drug Interaction between Amoxicillin and Aspirin
por: Zhang, Juanhong, et al.
Publicado: (2019)

The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
por: Yang, Dongming, et al.
Publicado: (2019)

Gut, oral and nasal microbiota and Parkinson’s disease
por: Shen, Liang
Publicado: (2020)

Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota
por: Yemula, Nehal, et al.
Publicado: (2021)

Curcumin Supplementation Ameliorates Bile Cholesterol Supersaturation in Hamsters by Modulating Gut Microbiota and Cholesterol Absorption
por: Hong, Ting, et al.
Publicado: (2022)

Gut Microbiota and Parkinson’s Disease: Implications for Faecal Microbiota Transplantation Therapy
por: Kang, Yongbo, et al.
Publicado: (2021)

Squamosamide Derivative FLZ Protects Retinal Pigment Epithelium Cells from Oxidative Stress through Activation of Epidermal Growth Factor Receptor (EGFR)-AKT Signaling
por: Cheng, Li-Bo, et al.
Publicado: (2014)

Enterococcus faecium Modulates the Gut Microbiota of Broilers and Enhances Phosphorus Absorption and Utilization
por: Wang, Weiwei, et al.
Publicado: (2020)

Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease
por: Vascellari, Sarah, et al.
Publicado: (2020)

Corrigendum: The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
por: Yang, Dongming, et al.
Publicado: (2020)

Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease
por: Palacios, Natalia, et al.
Publicado: (2021)

New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
por: Lorente-Picón, Marina, et al.
Publicado: (2021)

Evaluation of the Percutaneous Absorption of Drug Molecules in Zebrafish
por: Morikane, Daizo, et al.
Publicado: (2020)

Protection effect of gut microbiota composition and acetate absorption against hypertension-induced damages on the longevity population in Guangxi, China
por: Zhang, Qinren, et al.
Publicado: (2023)

Feeding intolerance alters the gut microbiota of preterm infants
por: Yuan, Zhenya, et al.
Publicado: (2019)

Role of the Lower and Upper Intestine in the Production and Absorption of Gut Microbiota-Derived PUFA Metabolites
por: Druart, Céline, et al.
Publicado: (2014)

2350: The role of gut microbiota in the susceptibility of Parkinson disease development
por: Koutzoumis, Dimitri, et al.
Publicado: (2018)

Gut microbiota: a potential therapeutic target for Parkinson’s disease
por: Baizabal-Carvallo, José Fidel
Publicado: (2020)

Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
por: Zhu, Manlian, et al.
Publicado: (2022)

The impact of Parkinson’s disease-associated gut microbiota on the transcriptome in Drosophila
por: Liu, Xin, et al.
Publicado: (2023)

Genome-Wide Identification of SnRK1 Catalytic α Subunit and FLZ Proteins in Glycyrrhiza inflata Bat. Highlights Their Potential Roles in Licorice Growth and Abiotic Stress Responses
por: Yang, Chao, et al.
Publicado: (2022)

Extension of the Life Span by Acarbose: Is It Mediated by the Gut Microbiota?
por: Wu, Baiyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q6t5jb6ne4ocot2mncfsj8lntb